Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Haematologica|July 13, 2023
IL6Myc mouse is an immunocompetent model for the development of aggressive multiple myelomaMichael D Pisano, Fumou Sun, Yan Cheng, et al.
Oncogene|July 6, 2022
FOXM1 regulates glycolysis and energy production in multiple myelomaYan Cheng, Fumou Sun, Krista Thornton, et al.
The Journal of Clinical Investigation|October 26, 2023
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesionsFumou Sun, Yan Cheng, Jin-Ran Chen, et al.
Cancers|March 13, 2025
Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone ResorptionDongzheng Gai, Perry C Caviness, Oxana P Lazarenko, et al.
Blood Cancer Journal|March 5, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencingJian-Rong Li, Shahram Arsang-Jang, Yan Cheng, et al.
Research Square|May 20, 2024
Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influxDongzheng Gai, Perry C Caviness, Oxana P Lazarenko, et al.
Cancer Biomarkers : Section a of Disease Markers|June 9, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myelomaFumou Sun, Yan Cheng, Catherine Ma, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2026
Radiation-induced remodeling of the T cell landscape in head and neck cancerAbdullah A Memon, Imaad Said, Ean Norenberg, et al.
Blood Cancer Journal|November 6, 2024
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stagesYan Cheng, Fumou Sun, Daisy V Alapat, et al.
The Journal of Clinical Investigation|July 26, 2022
CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiationDongzheng Gai, Jin-Ran Chen, James P Stewart, et al.
Pageof 4